{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:23:46Z","timestamp":1791062626885,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jbspin.2014.10.010","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T15:36:58Z","timestamp":1420040218000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Systemic sclerosis: Recent insights"],"prefix":"10.1016","volume":"82","author":[{"given":"Muriel","family":"Elhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.10.010_bib0005","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0010","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ajpath.2013.02.039","article-title":"Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension","volume":"182","author":"Ghatnekar","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0015","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0020","article-title":"Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis","author":"Maurer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0025","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/art.38078","article-title":"Endothelial injury in a transforming growth factor \u03b2-dependent mouse model of scleroderma induces pulmonary arterial hypertension","volume":"65","author":"Derrett-Smith","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0030","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/ar4349","article-title":"Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis","volume":"15","author":"Manetti","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.autrev.2013.05.002","article-title":"Systemic sclerosis at the crossroad of polyautoimmunity","volume":"12","author":"Elhai","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jbspin.2012.01.016","article-title":"Incomplete thymic involution in systemic sclerosis and rheumatoid arthritis","volume":"80","author":"Meunier","year":"2013","journal-title":"Joint Bone Spine Rev Rhum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","article-title":"Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis","volume":"72","author":"Avouac","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0055","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2012.06.005","article-title":"Experimental models of dermal fibrosis and systemic sclerosis","volume":"80","author":"Avouac","year":"2013","journal-title":"Joint Bone Spine Rev Rhum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0065","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar4672","article-title":"Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis","volume":"16","author":"Desallais","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0085","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0090","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0095","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0100","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2014.03.014","article-title":"Arterial vasculopathy in systemic sclerosis: computerized tomography (CT) angiographic features of macrovascular and microvascular upper limbs arteries","author":"Emad","year":"2014","journal-title":"Joint Bone Spine Rev Rhum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0115","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0120","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","article-title":"Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study","volume":"71","author":"Smith","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0125","first-page":"CD002069","article-title":"Calcium channel blockers for primary Raynaud's phenomenon","volume":"1","author":"Ennis","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0130","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0135","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0145","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0b013e3283588dcf","article-title":"Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management","volume":"24","author":"Shanmugam","year":"2012","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.jbspin.2014.10.010_bib0160","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"International Scleroderma Renal Crisis Study Investigators. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-Results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0165","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/annrheumdis-2012-202567","article-title":"Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis","volume":"73","author":"Avouac","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0175","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","author":"Coghlan","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0180","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/art.30432","article-title":"Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations","volume":"63","author":"Meune","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0185","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/art.38043","article-title":"Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension","volume":"65","author":"Codullo","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-011-0216-4","article-title":"Application of biomarkers to clinical trials in systemic sclerosis","volume":"14","author":"Lafyatis","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0200","doi-asserted-by":"crossref","DOI":"10.1002\/art.38623","article-title":"Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease","author":"Volkmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0205","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0210","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0215","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0220","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0225","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0230","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.30204","article-title":"Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis","volume":"63","author":"Dieud\u00e9","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0240","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0245","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0250","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.semarthrit.2013.10.004","article-title":"Tissue Doppler imaging in systemic sclerosis: a 3-year longitudinal study","volume":"43","author":"D\u2019Alto","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0255","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00025413","article-title":"Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?","volume":"42","author":"Coghlan","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0260","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jbspin.2012.10.009","article-title":"Endocardial and myocardial involvement in systemic sclerosis \u2013 is there a relevant inflammatory component?","volume":"80","author":"Dinser","year":"2013","journal-title":"Joint Bone Spine Rev Rhum"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0270","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/j.ejrad.2013.02.014","article-title":"Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI)","volume":"82","author":"Di Cesare","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0275","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.130386","article-title":"Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study","volume":"41","author":"Ghr\u00e9nassia","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0285","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0290","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acr.21964","article-title":"Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis","volume":"65","author":"Dor\u00e9","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0295","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0300","first-page":"166","article-title":"Treatment of early diffuse systemic sclerosis skin disease","volume":"31","author":"Frech","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0305","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","author":"Jordan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0310","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","article-title":"Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study","volume":"72","author":"Elhai","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0315","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1365-2133.2012.11186.x","article-title":"Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial","volume":"167","author":"Prey","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2014.10.010_bib0320","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"Van Laar","year":"2014","journal-title":"JAMA"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14002577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14002577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:29:54Z","timestamp":1717655394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14002577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1297319X14002577"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.10.010","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis: Recent insights","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}